Drawing for ELRAVIE RE2O

USPTO serial 99565276

ELRAVIE RE2O

Reviewed by CopyMark Law Group

Status 651
Filing date
Status date
Registration date
—
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ELRAVIE RE2O?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JAMES R MENKER

JAMES R MENKER HOLLEY & MENKER, PA60 Ocean Boulevard, Suite 3Atlantic Beach, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
003Laundry bleach; cosmetic preparations for skin care; wrinkle removing skin care preparations; beauty masks; mask pack for cosmetic purposes; sunscreen preparations; skin hydrators for cosmetic purposes; cosmetics; lotions for cosmetic purposes; shower gels; make-up; serums for cosmetic purposes; oils for perfumes and scents; nail art stickers; shampoos; toothpaste; non-medicated toiletry preparations; polishing preparations; cosmetics for animalsACTIVE—
005Syringes sold filled with pharmaceutical preparation for skin care; cells for medical purposes; collagen for medical purposes; pharmaceutical preparations for human purposes, namely, cellular function activating agents for medical purposes; pharmaceutical preparations for human purposes, namely, injectable dermal filler; tissue-regenerative pharmaceutical preparations, namely, pharmaceutical preparations and substances for the regeneration of damaged skin and tissue; air deodorizing preparations; bacterial preparations for medical purposes; implants comprising living tissue; human allograft tissue; transplants comprising living tissue, namely, biological skin tissue intended for subsequent implantation; surgical implants comprising living tissue; surgical implants comprised of living tissues, grown from stem cells; surgical implants comprised of living tissues, derived from stem cells; skin grafts; sanitizing wipes; surgical mesh comprised primarily of living tissueACTIVE—
010Drug delivery devices sold empty, namely, drug syringes; injection device for pharmaceuticals; artificial skin for surgical purposes; lasers for medical purposes; medical injection syringe, namely, syringes for medical purposes and for injections; medical skin care apparatus, namely, medical apparatus for measuring skin hydration, and electronic light therapy apparatus for the skin; medical apparatus for injecting fillers, namely, medial apparatus for injecting dermal filler into subcutaneous tissue; artificial skin, namely, skin substitute made of artificial materials for medical purposes; artificial biomaterials for augmentation of skin and tissue for medical purposes used in dermatology; skin regeneration therapy apparatus, namely, electronic light therapy apparatus for the skin; medical apparatus and instruments for use in dermatology; massaging apparatus for personal use; dental apparatus and instruments, namely, surgical apparatus and instruments for dental use; contraceptive apparatus; suture materialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2026GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 29, 2026CNSISUSPENSION INQUIRY WRITTEN—
Oct 29, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 1, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 1, 2026GNSLLETTER OF SUSPENSION E-MAILED—
May 1, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 27, 2026DOCKASSIGNED TO EXAMINER—
Apr 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 24, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance